GlassScriptPhysician profile
Ezra Burch
NPI 1346687894
$18,617.88
in general payments reported to CMS, 2019-2025
9 companies · $17K in 2025
The $17K reported for 2025 was more than what 92% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $150 · 2024: $1,010 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $2,373 · Travel and Lodging: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,565.06 |
| Food and Beverage | $2,372.74 |
| Travel and Lodging | $680.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $8,553.94 | 2024-2025 | Venovo, Bardex Nasopharyngeal Airway, Fluency Endovascular Stent Graft |
| Guerbet LLC | $8,065.06 | 2025 | |
| Boston Scientific Corporation | $677.25 | 2024-2025 | Embold Fibered, Therasphere Administration Set, Spyglass Discover |
| Inari Medical, INC. | $660.07 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $171.88 | 2024-2025 | Broadway 8, Flowtriever, Target |
| Penumbra, INC. | $149.98 | 2023 | Indigo System |
| Terumo Medical Corporation | $138.57 | 2025 | |
| Trisalus Life Sciences, INC. | $129.55 | 2024 | Trinav Infusion System |
| Siemens Medical Solutions USA, INC. | $71.58 | 2025 | Embozene, Varian Cryocare Touch System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ezra Burch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.